Nanomedicine News

RSS

Conference on Cancer Diagnostics to be Held from September 27 to 30, 2010

The American Association for Cancer Research will host its Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development from Sept. 27-30, 2010, at the Sheraton Denver Downtown in Denver...

22 Sep 2010

Magforce Nanotechnologies Releases Clinical Data on Magnetic Iron-Oxide Nanoparticles in Patients with Recurrent Glioblastoma Multiforme

MagForce Nanotechnologies AG (FSE:MF6) announced today the publication of clinical data from a clinical study examining the safety and efficacy of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy in patients with recurrent glioblastoma multiforme.

From MagForce Nanotechnologies AG 21 Sep 2010

Nano Israel 2010 Conference to be Held on November 8-9

The "Nano Israel 2010" Conference and the Exhibition accompanying will be held on November the 8th and the 9th in the Dan Panorama Hotel, Tel Aviv.

21 Sep 2010

New Nanoelectronics Technology Could Replace Conventional Microplate

The multi-welled microplate, long a standard tool in biomedical research and diagnostic laboratories, could become a thing of the past thanks to new electronic biosensing technology developed by a team of microelectronics engineers and biomedical scientists at the Georgia Institute of Technology.

From Georgia Institute of Technology 21 Sep 2010

Microspheres Helping Surgeons Accurately Locate Breast Cancers

A new material could help surgeons more accurately locate breast cancers, reduce the need for second surgeries and minimize pre-surgical discomfort for patients. Microscopic gas-filled spheres of silica, a porous glass, can mark the location of early-stage tumors to show their position using ultrasound imaging in the operating room.

19 Sep 2010

Emerging Class of Nanophosphors Holds Promise for Biomedical Applications

Fluorescent tags have become essential tools in a variety of medical applications ranging from drug discovery to diagnostics. The excitation wavelengths required for most common fluorophores either generate high levels of background fluorescence, which can swamp the signal, or cause photodamage in biological samples.

18 Sep 2010